New Hepatitis C treatment TGA registered

Hepatitis Virus - 3D Render
The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C.MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA for the treatment of chronic hepatitis C virus genotype 1 and 4 infection in adults.The regimen is a once-daily tablet taken for 12 weeks, and is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Medicines: the state of the nation
Next 'Codeine road trips' less likely, but there's still a way to go